$GRDN News

Statutory Profit Doesn't Reflect How Good Guardian Pharmacy Services' (NYSE:GRDN) Earnings Are

Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Guardian Pharmacy Services Q1 Earnings Call Highlights

The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Strong Q1 Beat And New Shelf Registration

Guardian Pharmacy Services, Inc. Q1 2026 Earnings Call Summary

Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $43

Guardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass Estimates

Guardian Pharmacy Services (NYSE:GRDN) Q1 2026 Earnings Beat and Guidance Hike Fail to Spark Stock Rally

Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance

Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript

Guardian Pharmacy Service Affirms FY2026 Sales Guidance of $1.400B-$1.420B vs $1.413B Est

Guardian Pharmacy Service Q1 Adj. EPS $0.29 Beats $0.23 Estimate, Sales $336.595M Beat $329.485M Estimate

Guardian Pharmacy Services to Report Q1 Earnings: What's in the Cards?

Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth

Guardian Pharmacy Services (GRDN) Reports Next Week: Wall Street Expects Earnings Growth

B of A Securities Initiates Coverage of Guardian Pharmacy Services (GRDN) with Buy Recommendation

B of A Securities Initiates Coverage On Guardian Pharmacy Service with Buy Rating, Announces Price Target of $42

Guardian Pharmacy Services, Inc. to Participate in the Bank of America 2026 Healthcare Conference

Assessing Guardian Pharmacy Services (GRDN) Valuation After Strong Recent Share Price Momentum

Guardian Pharmacy Services, Inc. to Report First Quarter 2026 Financial Results and Host Conference Call